Pharmacogenomics

noun (usually treated as singular)
/ˌfɑːrməkoʊdʒɪˈnɒmɪks/
The branch of genomics that studies how an individual's genetic makeup influences their response to pharmaceutical drugs, enabling the selection of optimal drug types and dosages tailored to a patient's genotype — the foundation of personalised or precision medicine.

✍️ Usage in a UPSC answer

As India advances its precision-medicine agenda under the Genome India Project, the integration of pharmacogenomics into public health care could drastically reduce adverse drug reactions and wasteful expenditure, though it simultaneously raises pressing questions of genetic data privacy and equitable access.

Synonyms

pharmacogeneticsprecision medicinepersonalised medicinegenomic medicineindividualised therapeutics

Antonyms

one-size-fits-all medicineempirical prescribingstandardised therapy

🌱 Word Family

pharmacogenomic (adj), pharmacogenomicist (n), pharmacogenetics (n), pharmacogenetic (adj)

🔡 Root

Greek pharmakon = drug; genos = race, kind; -omics = comprehensive study suffix; portmanteau coined late 1990s

📜 Etymology

A portmanteau of pharmacology (from Greek pharmakon, "drug") and genomics (from Greek genos, "race, kind" + the -omics suffix denoting comprehensive study); the field emerged in the late 1990s as the Human Genome Project made large-scale genetic analysis feasible.

🧠 Memory Hook

Break it as PHARMACO (drug) + GENOMICS (genes): "your GENES decide which PHARMACy drug works for you" -- medicine matched to your DNA.

🎯 How This Word Works in UPSC Writing

The study of how genetic variation affects response to drugs, and its value is concrete rather than futuristic. Inherited differences in drug-metabolising enzymes mean an identical dose produces very different blood concentrations in different people, so some patients suffer toxicity at standard doses while others derive no benefit at all, and testing before prescribing can prevent both outcomes. The Indian dimension is that most pharmacogenomic evidence derives from populations of European ancestry, while allele frequencies differ substantially across Indian populations, so imported reference data can actively mislead, which is precisely why building a catalogue of Indian genetic variation matters clinically and not merely for research. The obstacles are equally practical: the cost of testing weighed against the cost of an adverse reaction, the near-absence of pharmacogenomic guidance in routine prescribing, and the protection of genetic data, which is uniquely sensitive because it cannot be changed and discloses information about relatives who never consented.

⚖️ Don’t Confuse It With

Pharmacogenomics examines how variation across the genome affects drug response, while pharmacogenetics traditionally referred to single-gene effects, though the terms are now often used interchangeably. Precision or personalised medicine is the wider clinical approach of which this forms one component. Pharmacokinetics concerns what the body does to a drug and pharmacodynamics what the drug does to the body, and genetic variation bears on both. An adverse drug reaction is the harm such testing is intended to avert.

🇮🇳 Hindi Meaning

औषध जीनोमिकी (aushadh jīnomikī) or फार्माकोजीनोमिक्स.

Common Questions

How does pharmacogenomics reduce adverse drug reactions?
Genetic differences in drug-metabolising enzymes change how much active drug reaches the bloodstream, so testing beforehand identifies patients who would be poisoned or unhelped by a standard dose.
Why does Indian-specific genomic data matter?
Because most pharmacogenomic evidence comes from European-ancestry populations and allele frequencies differ across Indian groups, so imported reference data can give misleading guidance.
Relevant across:GS3 · Economy, Environment, S&T & Security

Tip: press Alt+S to hear pronunciation

Resources
Ujiyari Ujiyari — Current Affairs